Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Shortages (3)
- (-) Labelling and packaging (1)
- Advisory bodies and committees (219)
- Scheduling (national classification system) (59)
- Therapeutic goods regulation (42)
- Regulatory compliance (27)
- Manufacturing (26)
- In Vitro Diagnostic medical devices (IVDs) (25)
- Prescription medicines (23)
- Advertising (22)
- Non-prescription medicines (20)
- Unique Device Identification (UDI) hub (20)
- Registered complementary medicines (17)
- Complementary medicines (16)
- COVID-19 vaccines (14)
- Over the counter (OTC) medicines (10)
- Safety (10)
- Australian Register of Therapeutic Goods (ARTG) (9)
- Medical devices safety (9)
- Clinical trials (8)
- Legislation (8)
- Medicine safety (8)
- Vaping hub (8)
- Medicinal cannabis hub (5)
- Advanced therapies (2)
- Breast implant hub (2)
- Compliance and enforcement hub (2)
- Listed medicines (2)
- Pharmacovigilance (2)
- Alert/Advisory (1)
- Blood and blood components (1)
- Cosmetics (1)
- Import and export (1)
- TGA conformity assessment certification (1)
Search
4 result(s) found, displaying 1 to 4
-
PresentationsSee the upcoming changes in the PRAC – the new procedure document that will replace the Uniform Recalls Procedure for Therapeutic Goods (URPTG).
-
WebinarsThis webinar provides information on the TGA’s public consultation on the impacts, challenges and opportunities relating to medicine shortages.
-
PresentationsA presentation discussing the lessons learnt from the Actemra (tocilizumab) shortage.
-
WebinarsAn overview of TGA's proposed safety and quality requirements for unapproved vaporiser nicotine products.